Vaccine Therapy in Treating Patients With Breast Cancer
Public ClinicalTrials.gov record NCT00524277. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Trial of the HER2/Neu Peptide GP2 + GM-CSF Vaccine vs GM-CSF Alone in HLA-A2+ OR the Modified HER2/Neu Peptide AE37 + GM-CSF Vaccine vs GM-CSF Alone in HLA-A2- Node-Positive and High-Risk Node-Negative Breast Cancer Patients
Study identification
- NCT ID
- NCT00524277
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- San Antonio Military Medical Center
- Federal
- Enrollment
- 456 participants
Conditions and interventions
Conditions
Interventions
- GP2 peptide + GM-CSF vaccine Biological
- GM-CSF (sargramostim) Biological
- AE37 + GM-CSF vaccine Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2006
- Primary completion
- Dec 30, 2014
- Completion
- Mar 30, 2017
- Last update posted
- Mar 29, 2020
2007 – 2017
United States locations
- U.S. sites
- 11
- U.S. states
- 6
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sibley Memorial Hospital | Washington D.C. | District of Columbia | 20016 | — |
| University of Hawaii Cancer Center | Honolulu | Hawaii | 96813 | — |
| MedStar Union Memorial Hospital | Baltimore | Maryland | 21218 | — |
| MedStar Good Samaritan Hospital Cancer Center | Baltimore | Maryland | 21239 | — |
| Walter Reed National Military Medical Center | Bethesda | Maryland | 20889 | — |
| Wake Forest University Comprehensive Cancer Center | Winston-Salem | North Carolina | 27157-1096 | — |
| Carl R. Darnall Army Medical Center | Fort Hood | Texas | 76544-4752 | — |
| San Antonio Army Medical Center | Fort Sam Houston | Texas | 78234-6200 | — |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030-4009 | — |
| STOH Clinical Research | San Antonio | Texas | 78229 | — |
| Madigan Army Medical Center - Tacoma | Tacoma | Washington | 98431-5000 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00524277, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 29, 2020 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00524277 live on ClinicalTrials.gov.